Summary Of Tositumomab-FDF

Chemical Name

Tositumomab

CAS No.

208921-02-2

Molecular Formula

--

Innovator

Developer

Indication

Non-Hodgkins Lymphoma

Therapeutic Area

Oncology

Market Status

Launched

Approval Year

Patent Expiry